Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,270Revenue (TTM) $M141Net Margin (%)-89.3Altman Z-Score2.6
Enterprise Value $M1,942EPS (TTM) $-0.8Operating Margin %-80.4Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.6Pre-tax Margin (%)-89.3Higher ROA y-yN
Price/Book10.010-y EBITDA Growth Rate %--Quick Ratio5.4Cash flow > EarningsY
Price/Sales13.95-y EBITDA Growth Rate %--Current Ratio5.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-42.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-237.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M197ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ARRY

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

ARRY is held by these investors:

ARRY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
VAN LUNSEN GIL JDirector 2017-09-29Sell39,928$12.36-6.8view
LEFKOFF KYLEDirector 2017-09-29Sell38,865$12.31-6.42view
LEFKOFF KYLEDirector 2017-03-31Sell45,000$8.9229.15view
BAUM CHARLES MDirector 2017-03-28Sell25,000$9.2724.27view
Redmile Group, LLC10% Owner 2016-09-28Sell2,492,578$6.3681.13view
Redmile Group, LLC10% Owner 2016-09-15Sell400,000$3.5229.14view
Redmile Group, LLC10% Owner 2016-09-15Buy400,000$3.51228.21view
Redmile Group, LLC10% Owner 2016-01-20Buy300,000$3.19261.13view
Redmile Group, LLC10% Owner 2016-01-12Buy75,000$3.6220view
Redmile Group, LLC10% Owner 2016-01-11Buy925,000$3.67213.9view

Quarterly/Annual Reports about ARRY:

News about ARRY:

Articles On GuruFocus.com
Array BioPharma Announces Private Exchange of $107 Million of its 3.00% Convertible Senior Notes due Nov 16 2017 
Array BioPharma Reports Initial Results From Novel Immunotherapy Combination At The Society For Immu Nov 13 2017 
Array BioPharma To Present At The 2017 Stifel Healthcare Conference Nov 08 2017 
Factors of Influence in 2018, Key Indicators and Opportunity within AGNC Investment, Discovery Commu Nov 08 2017 
Steven Cohen Takes Stake in Karyopharm Therapeutics Nov 07 2017 
Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2018 Oct 31 2017 
Array Biopharma To Report Financial Results For The First Quarter Of Fiscal 2018 On October 31, 2017 Oct 24 2017 
Steven Cohen Doubles Down on Sickle Cell Disease Therapeutics Company Global Blood Oct 04 2017 
Array BioPharma To Present At The 2017 Cantor Fitzgerald Global Healthcare Conference Sep 19 2017 
Array BioPharma Announces Closing of Public Offering and Full Exercise of Option to Purchase Additio Sep 19 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat